ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 972

$907K Total Retail Price of All Prescriptions

Rank: 81 out of 972

285 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 285 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 285 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 13,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
AMLODIPINE BESYLATE 649 585 1 4
WARFARIN SODIUM 573 500 2 12
LISINOPRIL 464 403 3 1
FUROSEMIDE 411 345 4 7
METOPROLOL TARTRATE 406 366 5 9
HYDROCODONE-ACETAMINOPHEN 396 314 S3 6 6
LEVOTHYROXINE SODIUM 391 338 7 3
DONEPEZIL HCL 369 356 8 26
NAMENDA 344 344 9 38
SIMVASTATIN 331 282 10 2
OMEPRAZOLE 308 229 11 5
ATORVASTATIN CALCIUM 299 286 12 11
MIRTAZAPINE 215 202 13 46
CARVEDILOL 208 205 14 21
GABAPENTIN 205 173 15 14
POTASSIUM CHLORIDE 204 167 16 13
GLIPIZIDE 201 174 17 59
CITALOPRAM HBR 195 165 18 19
LANTUS 189 166 19 44
FAMOTIDINE 188 167 20 73
SERTRALINE HCL 182 136 21 25
HYDRALAZINE HCL 181 172 22 69
ZOLPIDEM TARTRATE 166 153 23 23
ATENOLOL 161 134 24 18
TRAZODONE HCL 147 132 25 35
CLOPIDOGREL 147 120 25 37
DOXAZOSIN MESYLATE 145 144 27 82
MONOJECT INSULIN SYRINGE 143 143 10 28 229
QUETIAPINE FUMARATE 138 97 29 83
DIVALPROEX SODIUM 135 85 30 96
ALENDRONATE SODIUM 134 124 31 27
LEVOFLOXACIN 132 126 32 98
TRAMADOL HCL 120 111 33 15
NEXIUM 115 109 34 30
CYMBALTA 114 111 35 49
ESCITALOPRAM OXALATE 112 103 36 65
ISOSORBIDE MONONITRATE ER 110 95 37 43
LEVETIRACETAM 108 68 38 111
CARBIDOPA-LEVODOPA 104 94 39 87
PANTOPRAZOLE SODIUM 102 95 40 41
METOPROLOL SUCCINATE 100 52 41 16
IPRATROPIUM-ALBUTEROL 99 95 42 132
PRAVASTATIN SODIUM 99 91 42 20
KLOR-CON 10 98 98 44 68
NOVOLOG 95 88 45 100
TAMSULOSIN HCL 94 75 46 29
EXELON 91 81 47 125
NOVOLIN R 90 84 48 185
LIDODERM 89 83 49 115
PLAVIX 89 74 49 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 79 51 109
HALOPERIDOL 81 13 52 168
NITROFURANTOIN MONO-MACRO 80 75 53 254
RANITIDINE HCL 75 52 54 24
OXYCODONE-ACETAMINOPHEN 75 67 S2 54 80
TERAZOSIN HCL 73 46 56 120
POLYETHYLENE GLYCOL 3350 72 67 57 67
OXYBUTYNIN CHLORIDE ER 70 52 58 128
PATANOL 69 49 59 278
METFORMIN HCL 67 53 60 8
MIDODRINE HCL 63 47 61 289
HYDROCHLOROTHIAZIDE 62 44 62 10
FLUOXETINE HCL 60 48 63 60
NYSTOP 60 58 63 220
SPIRIVA 60 49 63 56
ISOSORBIDE DINITRATE 59 55 66 352
RENVELA 59 29 66 274
INSULIN SYRINGE 59 52 66 84
RISPERIDONE 57 40 69 76
CLONIDINE HCL 56 45 70 57
FINASTERIDE 55 52 71 77
DIGOXIN 55 43 71 52
BUSPIRONE HCL 55 18 71 105
FENTANYL 55 52 S2 71 89
ABILIFY 53 47 75 137
LOPERAMIDE 52 45 76 261
NYSTATIN 50 36 77 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.